Intrinsiqs

Is Emergent BioSolutions Inc. overvalued?

Emergent BioSolutions Inc. (EBS) — key valuation metrics and fundamentals.

No verdict
Price
$4.59
Fair value
—
Current P/E
—
Normal P/E
23.5
Market cap
$236.8M
Dividend yield
0.0%
Return on equity
-35.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EBS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.